NTRB
Nutriband Inc

2,399
Mkt Cap
$57.53M
Volume
27,298.00
52W High
$9.42
52W Low
$2.98
PE Ratio
-1.63
NTRB Fundamentals
Price
$4.68
Prev Close
$4.78
Open
$4.79
50D MA
$6.76
Beta
0.75
Avg. Volume
46,176.65
EPS (Annual)
-$0.9882
P/B
6.62
Loading...
Loading...
News
all
press releases
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +70.37% and -15.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
More News
News Placeholder
Nutriband (NASDAQ:NTRB) Rating Increased to Hold at Zacks Research
Zacks Research raised Nutriband from a "strong sell" rating to a "hold" rating in a report on Tuesday...
MarketBeat·11d ago
News Placeholder
TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates
TELA Bio (TELA) delivered earnings and revenue surprises of -11.76% and -5.53%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
News Placeholder
Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates
Korro Bio, Inc. (KRRO) delivered earnings and revenue surprises of +26.44% and -27.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Metagenomi (MGX) Reports Q3 Loss, Lags Revenue Estimates
Metagenomi (MGX) delivered earnings and revenue surprises of +8.33% and -6.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago
News Placeholder
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of +166.67% and +78.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates
Nutriband (NTRB) delivered earnings and revenue surprises of -1,147.06% and -11.77%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Phibro (PAHC) delivered earnings and revenue surprises of +9.62% and +4.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of -123.64% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -12.20% and +3.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago

Latest NTRB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.